Table of Contents
International Journal of Evolutionary Biology
Volume 2014 (2014), Article ID 108291, 8 pages
http://dx.doi.org/10.1155/2014/108291
Review Article

Genetics of Sub-Saharan African Human Population: Implications for HIV/AIDS, Tuberculosis, and Malaria

1Department of Medical Microbiology, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda
2School of Allied Health Sciences, International Health Sciences University, P.O. Box 7782, Kampala, Uganda

Received 28 April 2014; Revised 9 July 2014; Accepted 1 August 2014; Published 18 August 2014

Academic Editor: Yoko Satta

Copyright © 2014 Gerald Mboowa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global Fact Sheet, Joint United Nations Programme on HIV and AIDS, 20 November 2012.
  2. UNAIDS Report on the Global AIDS Epidemic 2012.
  3. S. A. Tishkoff and S. M. Williams, “Genetic analysis of African populations: Human evolution and complex disease,” Nature Reviews Genetics, vol. 3, no. 8, pp. 611–621, 2002. View at Google Scholar · View at Scopus
  4. R. Cagliani and M. Sironi, “Pathogen-driven selection in the human genome,” International Journal of Evolutionary Biology, vol. 10, pp. 1155–1161, 2013. View at Google Scholar
  5. M. Fumagalli, M. Sironi, U. Pozzoli, A. Ferrer-Admettla, L. Pattini, and R. Nielsen, “Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution,” PLoS Genetics, vol. 7, no. 11, Article ID e1002355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. B. Jorde, W. S. Watkins, and M. J. Bamshad, “Population genomics: a bridge from evolutionary history to genetic medicine,” Human Molecular Genetics, vol. 10, no. 20, pp. 2199–2207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. L. B. Jorde, W. S. Watkins, M. J. Bamshad et al., “The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data,” The American Journal of Human Genetics, vol. 66, no. 3, pp. 979–988, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Meya and K. P. W. J. McAdam, “The TB pandemic: an old problem seeking new solutions,” Journal of Internal Medicine, vol. 261, no. 4, pp. 309–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Kampmann, C. Hemingway, A. Stephens et al., “Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ,” Journal of Clinical Investigation, vol. 115, no. 9, pp. 2480–2488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. C. Hill, R. H. Brookes, I. M. O. Adetifa et al., “Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis,” Pediatrics, vol. 117, no. 5, pp. 1542–1548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Newton, A. J. Brent, S. Anderson, E. Whittaker, and B. Kampmann, “Paediatric tuberculosis,” The Lancet Infectious Diseases, vol. 8, no. 8, pp. 498–510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Gonzalez, M. Bamshad, N. M. Sato et al., “Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 21, pp. 12004–12009, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Gonzalez, H. Kulkarni, H. Bolivar et al., “The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility,” Science, vol. 307, no. 5714, pp. 1434–1440, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Schliekelman, C. Garner, and M. Slatkin, “Natural selection and resistance to HIV,” Nature, vol. 411, no. 6837, pp. 545–546, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. A. D. Sullivan, J. Wigginton, and D. Kirschner, “The coreceptor mutation CCR5δ32 influences the dynamics of hiv epidemics and is selected for by HIV,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10214–10219, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Winkler, P. An, and S. J. O'Brien, “Patterns of ethnic diversity among the genes that influence AIDS,” Human Molecular Genetics, vol. 13, no. 1, pp. 9–19, 2004. View at Google Scholar
  17. W. He, S. Neil, H. Kulkarni et al., “Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility,” Cell Host and Microbe, vol. 4, no. 1, pp. 52–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Lama and V. Planelles, “Host factors influencing susceptibility to HIV infection and AIDS progression,” Retrovirology, vol. 4, article 52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. H. Salem, E. Farid, R. Fadel et al., “Distribution of four HIV type 1-resistance polymorphisms (CCR5-Δ32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population,” AIDS Research and Human Retroviruses, vol. 25, no. 10, pp. 973–977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Gonzalez, R. Dhanda, M. Bamshad et al., “Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5199–5204, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Su, G. Sun, D. Lu et al., “Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-Δ32) in global populations,” European Journal of Human Genetics, vol. 8, no. 12, pp. 975–979, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. M. W. Smith, M. Dean, M. Carrington et al., “Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia growth and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter hemophilia cohort study (MHCS), San Francisco City Cohort (SFCC), ALIVE study,” Science, vol. 277, pp. 959–965, 1997. View at Google Scholar
  23. S. Mummidi, S. S. Ahuja, E. Gonzalez et al., “Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression,” Nature Medicine, vol. 4, no. 7, pp. 786–793, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. P. An, M. P. Martin, G. W. Nelson et al., “Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans,” AIDS, vol. 14, no. 14, pp. 2117–2122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Martinson, N. H. Chapman, D. C. Rees, Y. T. Liu, and J. B. Clegg, “Global distribution of the CCR5 gene 32-basepair deletion,” Nature Genetics, vol. 16, no. 1, pp. 100–103, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Barmania, M. Potgieter, and M. S. Pepper, “Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals,” International Journal of Infectious Diseases, vol. 17, no. 12, pp. e1148–e1153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Aklillu, L. Odenthal-Hesse, J. Bowdrey et al., “CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans,” BMC Infectious Diseases, vol. 13, article 536, 2013. View at Google Scholar
  28. M. Sadam, T. Karki, K. Huik et al., “CCL3L1 variable gene copy number influence on the susceptibility to HIV-1/AIDS among estonian intravenous drug user,” in Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections (CROI '08), Abstract 296, 2008.
  29. T. Nakajima, H. Ohtani, T. Naruse et al., “Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia,” Immunogenetics, vol. 59, no. 10, pp. 793–798, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Kulkarni, V. C. Marconi, B. K. Agan et al., “Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy,” PLoS ONE, vol. 3, no. 11, Article ID e3671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Zapata, W. Aguilar-Jiménez, N. Pineda-Trujillo, W. Rojas, H. Estrada, and M. T. Rugeles, “Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in sero-discordant couples from Colombia,” AIDS Research and Human Retroviruses, vol. 29, no. 12, pp. 1594–1603, 2013. View at Google Scholar
  32. B. Lee, B. J. Doranz, S. Rana et al., “Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4,” Journal of Virology, vol. 72, no. 9, pp. 7450–7458, 1998. View at Google Scholar · View at Scopus
  33. S. Mummidi, M. Bamshad, S. S. Ahuja et al., “Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA: Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus,” Journal of Biological Chemistry, vol. 275, no. 25, pp. 18946–18961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone, “Interleukin-10 determines viral clearance or persistence in vivo,” Nature Medicine, vol. 12, no. 11, pp. 1301–1309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Ejrnaes, C. M. Filippi, M. M. Martinic et al., “Resolution of a chronic viral infection after interleukin-10 receptor blockade,” The Journal of Experimental Medicine, vol. 203, no. 11, pp. 2461–2472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. D. D. Naicker, L. Werner, E. Kormuth et al., “Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis,” Journal of Infectious Diseases, vol. 200, no. 3, pp. 448–452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Abu-Raddad, P. Patnaik, and J. G. Kublin, “Dual infection with HIV and malaria fuels the spread of both diseases in Sub-Saharan Africa,” Science, vol. 314, no. 5805, pp. 1603–1606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. C. J. L. Murray, K. Styblo, and A. Rouillon, “Tuberculosis in developing countries: Burden, intervention and cost,” Bulletin of the International Union Against Tuberculosis and Lung Disease, vol. 65, no. 1, pp. 6–24, 1990. View at Google Scholar · View at Scopus
  39. G. S. Cooke and M. R. Siddiqui, “Host genetics and the dissection of mycobacterial immunity,” Clinical and Experimental Immunology, vol. 135, no. 1, pp. 9–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. H. McShane, “Susceptibility to tuberculosis—the importance of the pathogen as well as the host,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 20–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Selvaraj, H. Uma, A. M. Reetha et al., “HLA antigen profile in pulmonary tuberculosis patients and their spouses,” Indian Journal of Medical Research, vol. 107, pp. 155–158, 1998. View at Google Scholar · View at Scopus
  42. M. Ravikumar, V. Dheenadhayalan, K. Rajaram et al., “Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India,” Tubercle and Lung Disease, vol. 79, no. 5, pp. 309–317, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Dubaniewicz, B. Lewko, G. Moszkowska, B. Zamorska, and J. Stepinski, “Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis,” International Journal of Infectious Diseases, vol. 4, no. 3, pp. 129–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. A. E. Goldfeld, J. C. Delgado, S. Thim et al., “Association of an HLA-DQ allele with clinical tuberculosis,” Journal of the American Medical Association, vol. 279, no. 3, pp. 226–228, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Bornman, S. J. Campbell, K. Fielding et al., “Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study,” Journal of Infectious Diseases, vol. 190, no. 9, pp. 1631–1641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Bellamy, C. Ruwende, T. Corrah et al., “Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene,” Journal of Infectious Diseases, vol. 179, no. 3, pp. 721–724, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Wilkinson, M. Llewelyn, Z. Toossi et al., “Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study,” The Lancet, vol. 355, no. 9204, pp. 618–621, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Selvaraj, P. R. Narayanan, and A. M. Reetha, “Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients and resistance in female contacts,” Indian Journal of Medical Research, vol. 111, pp. 172–179, 2000. View at Google Scholar · View at Scopus
  49. J. M. Blackwell, S. E. Jamieson, and D. Burgner, “HLA and infectious diseases,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 370–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. The Global Burden of Disease: 2004 Update, World Health Organization, Geneva, Switzerland, 2008, http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_AnnexA.pdf.
  51. F. Prugnolle, A. Manica, M. Charpentier, J. F. Guégan, V. Guernier, and F. Balloux, “Pathogen-driven selection and worldwide HLA class I diversity,” Current Biology, vol. 15, no. 11, pp. 1022–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. L. H. Miller, “Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 7, pp. 2415–2419, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. G. S. Cooke and A. V. S. Hill, “Genetics of susceptibility to human infectious disease,” Nature Reviews Genetics, vol. 2, no. 12, pp. 967–977, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. M. D. Grmek, Diseases in the Ancient Greek World, Johns Hopkins Press, Baltimore, Md, USA, 1989.
  55. D. Brothweii and A. T. Sandison, Diseases in Antiquity-A Survey of the Diseases, Injuries and Surgery of Early Populations, Charles Thomas, Springfield, Ill, USA, 1967.
  56. G. E. Bushnell, A Study of the Epidemiology of Tuberculosis, with Especial Reference to Tuberculosis of the Tropics and of the Negro Race, William Wood & Co, New York, NY, USA, 1920.
  57. N. Nuteis, Medical Problems of Newly Contacted Indian Group, vol. 165, Pan American Health Organization, Scientific Publications, Washington, DC, USA, 1968.
  58. W. W. Stead, “Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering?” Annals of Internal Medicine, vol. 116, no. 11, pp. 937–941, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Wang and H. Wang, “A genome-wide association study primer for clinicians,” Taiwanese Journal of Obstetrics and Gynecology, vol. 48, no. 2, pp. 89–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Bellamy, C. Ruwende, T. Corrah, K. P. W. J. McAdam, H. C. Whittle, and A. V. S. Hill, “Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans,” The New England Journal of Medicine, vol. 338, no. 10, pp. 640–644, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Bellamy, N. Beyers, K. P. W. J. McAdam et al., “Genetic susceptibility to tuberculosis in Africans: a genome-wide scan,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 8005–8009, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Das, M. S. Koo, B. H. Kim et al., “Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 32, pp. e2997–e3006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. W. W. Stead, J. W. Senner, W. T. Reddick, and J. P. Lofgren, “Racial differences in susceptibility to infection by Mycobacterium tuberculosis,” The New England Journal of Medicine, vol. 322, no. 7, pp. 422–427, 1990. View at Google Scholar · View at Scopus
  64. X. Zhong, L. Leng, A. Beitin et al., “Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies.,” Nucleic Acids Research, vol. 33, no. 13, pp. e121–e137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. S. A. Tishkoff, R. Varkonyi, N. Cahinhinan et al., “Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance,” Science, vol. 293, no. 5529, pp. 455–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. C. C. Khor, F. O. Vannberg, S. J. Chapman et al., “CISH and susceptibility to infectious diseases,” The New England Journal of Medicine, vol. 362, pp. 22–32, 2010. View at Google Scholar
  67. S. Parikh and P. J. Rosenthal, “Human genetics and malaria: relevance for the design of clinical trials,” Journal of Infectious Diseases, vol. 198, no. 9, pp. 1255–1257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. P. C. Sabeti, D. E. Reich, J. M. Higgins et al., “Detecting recent positive selection in the human genome from haplotype structure,” Nature, vol. 419, no. 6909, pp. 832–837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. D. L. Hartl, “The origin of malaria: mixed messages from genetic diversity,” Nature Reviews Microbiology, vol. 2, no. 1, pp. 15–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Ohashi, I. Naka, J. Patarapotikul et al., “Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection,” The American Journal of Human Genetics, vol. 74, no. 6, pp. 1198–1208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. T. D. White, B. Asfaw, D. DeGusta et al., “Pleistocene Homo sapiens from Middle Awash, Ethiopia,” Nature, vol. 423, no. 6941, pp. 742–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Ruwende and A. Hill, “Glucose-6-phosphate dehydrogenase deficiency and malaria,” Journal of Molecular Medicine, vol. 76, no. 8, pp. 581–588, 1998. View at Publisher · View at Google Scholar · View at Scopus
  73. P. J. Mason, J. M. Bautista, and F. Gilsanz, “G6PD deficiency: the genotype-phenotype association,” Blood Reviews, vol. 21, no. 5, pp. 267–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. A. C. Allison and D. F. Clyde, “Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase.,” British Medical Journal, vol. 1, no. 5236, pp. 1346–1349, 1961. View at Publisher · View at Google Scholar · View at Scopus
  75. R. W. Snow, C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay, “The global distribution of clinical episodes of Plasmodium falciparum malaria,” Nature, vol. 434, no. 7030, pp. 214–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. T. G. Clark, A. E. Fry, S. Auburn et al., “Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility,” European Journal of Human Genetics, vol. 17, no. 8, pp. 1080–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. L. H. Miller, S. J. Mason, D. F. Clyde, and M. H. McGinniss, “The resistance factor to Plasmodium vivax in blacks. The Duffy blood group genotype, FyFy,” The New England Journal of Medicine, vol. 295, no. 6, pp. 302–304, 1976. View at Publisher · View at Google Scholar · View at Scopus
  78. R. L. Culleton, T. Mita, M. Ndounga et al., “Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing,” Malaria Journal, vol. 7, pp. 174–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. L. E. Mombo, F. Ntoumi, C. Bisseye et al., “Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren,” The American Journal of Tropical Medicine and Hygiene, vol. 68, no. 2, pp. 186–190, 2003. View at Google Scholar · View at Scopus
  80. M. J. Mackinnon, T. W. Mwangi, R. W. Snow, K. Marsh, and T. N. Williams, “Heritability of malaria in Africa,” PLoS Medicine, vol. 2, no. 12, article e340, pp. 1253–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Schofield, J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig, “γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites,” Nature, vol. 330, no. 6149, pp. 664–666, 1987. View at Publisher · View at Google Scholar · View at Scopus
  82. S. G. S. Vreden, M. F. van den Broek, M. C. Oettinger, J. P. Verhave, J. H. E. T. Meuwissen, and R. W. Sauerwein, “Cytokines inhibit the development of liver schizonts of the malaria parasite plasmodium berghei in vivo,” European Journal of Immunology, vol. 22, no. 9, pp. 2271–2275, 1992. View at Publisher · View at Google Scholar · View at Scopus
  83. P. D. Crompton, B. Traore, K. Kayentao et al., “Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria,” Journal of Infectious Diseases, vol. 198, no. 9, pp. 1265–1275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Gabara, “Developed nations should invest in African universities,” BuaNews, 2009. View at Google Scholar
  85. D. J. Terlouw, M. A. Aidoo, V. Udhayakumar et al., “Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya,” Journal of Infectious Diseases, vol. 186, no. 11, pp. 1661–1668, 2002. View at Publisher · View at Google Scholar · View at Scopus